Delivery Order SPE2DB20D9127-SPE2DB25FPQM7

Award Date 5/7/25
Potential Completion Date 5/29/25
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $25,106.30 and a period of performance through May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $10,270.50, is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order was issued under a $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which runs through December 31, 2025. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $18,086.64 and is a firm fixed-price delivery order contract with a performance period through May 29, 2025. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, with a ceiling value of $1,407.16 and an ultimate completion date of September 12, 2023. The contract type is firm fixed price. This award is part of a larger indefinite delivery contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,487.22, is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,317.32 firm fixed-price contract is to provide EXPAREL 266 MG/20 ML VIAL 20ML to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $7,461.66 and an ultimate completion date of September 16, 2024. It is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,133.84, is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML. The contract is a firm fixed-price delivery order with a completion date of May 24, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,043.32 contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, a specialized pharmaceutical product. The contract is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, at a ceiling value of $6,028.88. The contract is a firm fixed-price delivery order without any set-aside designation, and has an ultimate completion date of May 21, 2025. DMS Pharmaceutical Group Inc. holds...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB25FPQM7
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $9,043.32 and a period of performance through May 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 8/6/25, 9:53 AM